3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development

Author:   Michael A. Repka ,  Nigel Langley
Publisher:   Springer International Publishing AG
Edition:   2024 ed.
Volume:   44
ISBN:  

9783031460142


Pages:   288
Publication Date:   02 December 2023
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $362.22 Quantity:  
Add to Cart

Share |

3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development


Overview

This inclusive text describes 3D Printing for pharmaceutical applications, including emerging 3D technologies. The book focuses on the functionality of the materials/biomaterials used for the preparation of dosage forms and devices, fundamentals for preparing these systems and novel applications using these additive manufacturing techniques.  Also, the text includes clinical relevance and regulatory considerations for the future of personalized medicine. Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided.  Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.  

Full Product Details

Author:   Michael A. Repka ,  Nigel Langley
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   2024 ed.
Volume:   44
Weight:   0.617kg
ISBN:  

9783031460142


ISBN 10:   3031460146
Pages:   288
Publication Date:   02 December 2023
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Overview of Pharmaceutical 3D Printing Technologies.- Clinical Benefit of 3D Printed Products.- Characterization or Quality Control of 3D Printed Products.- Polymers for HME based 3D Printing.- Cellulosic Polymers.-  API and Polymer Selection Formulation and Process Variables.-  Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D.-  Future Trends Including Novel Polymeric Excipients  Designed for Purpose Bioprinting.

Reviews

Author Information

Dr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks. Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing.  Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas. 

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List